These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14532284)

  • 1. Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52.
    Atkinson PG; Coope HJ; Rowe M; Ley SC
    J Biol Chem; 2003 Dec; 278(51):51134-42. PubMed ID: 14532284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway.
    Eliopoulos AG; Caamano JH; Flavell J; Reynolds GM; Murray PG; Poyet JL; Young LS
    Oncogene; 2003 Oct; 22(48):7557-69. PubMed ID: 14576817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 regulates the processing of NF-kappaB2 p100 to p52.
    Coope HJ; Atkinson PG; Huhse B; Belich M; Janzen J; Holman MJ; Klaus GG; Johnston LH; Ley SC
    EMBO J; 2002 Oct; 21(20):5375-85. PubMed ID: 12374738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
    Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells.
    Hatada EN; Do RK; Orlofsky A; Liou HC; Prystowsky M; MacLennan IC; Caamano J; Chen-Kiang S
    J Immunol; 2003 Jul; 171(2):761-8. PubMed ID: 12847243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
    Song YJ; Kang MS
    Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-kappa B/Rel family proteins.
    Paine E; Scheinman RI; Baldwin AS; Raab-Traub N
    J Virol; 1995 Jul; 69(7):4572-6. PubMed ID: 7769726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines.
    Saito N; Courtois G; Chiba A; Yamamoto N; Nitta T; Hironaka N; Rowe M; Yamamoto N; Yamaoka S
    J Biol Chem; 2003 Nov; 278(47):46565-75. PubMed ID: 12968033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenes, tumor suppressors and p52 NF-kappaB.
    Perkins ND
    Oncogene; 2003 Oct; 22(48):7553-6. PubMed ID: 14576816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells.
    Pai S; O'Sullivan BJ; Cooper L; Thomas R; Khanna R
    J Virol; 2002 Feb; 76(4):1914-21. PubMed ID: 11799186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-1 Tax enhances NF-kappa B2 expression and binds to the products p52 and p100, but does not suppress the inhibitory function of p100.
    Murakami T; Hirai H; Suzuki T; Fujisawa J; Yoshida M
    Virology; 1995 Feb; 206(2):1066-74. PubMed ID: 7856081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism.
    Mordmüller B; Krappmann D; Esen M; Wegener E; Scheidereit C
    EMBO Rep; 2003 Jan; 4(1):82-7. PubMed ID: 12524526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.
    Mohr CF; Kalmer M; Gross C; Mann MC; Sterz KR; Kieser A; Fleckenstein B; Kress AK
    Cell Commun Signal; 2014 Jul; 12():46. PubMed ID: 25105941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for protein kinase Ctheta (PKCtheta) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-kappaB activation.
    Li Y; Sedwick CE; Hu J; Altman A
    J Biol Chem; 2005 Jan; 280(2):1217-23. PubMed ID: 15536066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
    Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
    Thornburg NJ; Raab-Traub N
    J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100.
    Derudder E; Dejardin E; Pritchard LL; Green DR; Korner M; Baud V
    J Biol Chem; 2003 Jun; 278(26):23278-84. PubMed ID: 12709443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of NF-kappa B2 p100 processing by its cis-acting domain.
    Qing G; Qu Z; Xiao G
    J Biol Chem; 2005 Jan; 280(1):18-27. PubMed ID: 15485830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.
    Kung CP; Raab-Traub N
    J Virol; 2008 Jun; 82(11):5486-93. PubMed ID: 18367518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
    Huen DS; Henderson SA; Croom-Carter D; Rowe M
    Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.